Todd Davis
Chief Executive Officer chez LIGAND PHARMACEUTICALS INCORPORATED
Fortune : 9 M $ au 31/03/2024
Profil
Todd C.
Davis is the founder of Healthcare Royalty Management LLC, established in 2007, where he holds the title of Managing Partner.
He is also the founder of Royaltyrx Capital LLC, founded in 2018, where he is currently the Managing Partner.
In his current roles, Mr. Davis is the Chief Executive Officer & Director at Ligand Pharmaceuticals, Inc. since 2007, Chairman & Chief Executive Officer at Benuvia Therapeutics, Inc., Chairman at Helomics Corp., Chairman at Chromocell Therapeutics Corp.
since 2023, Director at Harvard Business School Health Industry Alumni Association, Director at Palvella Therapeutics, Inc. since 2017, and Director at Virocell Biologics Ltd.
Previously, Mr. Davis served as Vice Chairman at Suneva Medical, Inc., Independent Director at BioDelivery Sciences International, Inc. from 2018 to 2022, Director at AcuFocus, Inc., Director at Verus Pharmaceuticals, Inc., Managing Director at Cowen Group, Inc. from 2007 to 2009, Director at Artes Medical, Inc. in 2008, Director at Nuron Biotech, Inc., Independent Director at Vaxart, Inc. from 2019 to 2023, Principal at Abbott Laboratories from 1990 to 1995, Partner at Apax Partners, Inc. from 2001 to 2006, Principal at Elan Pharmaceuticals LLC from 1997 to 2001, and Partner at Paul Capital Partners LP.
Mr. Davis obtained his undergraduate degree from the United States Naval Academy in 1983 and an MBA from Harvard Business School in 1997.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 25/03/2024 | 120 160 ( 0,68% ) | 9 M $ | 31/03/2024 | |
| 21/02/2024 | 29 167 ( 0,51% ) | 76 418 $ | 31/03/2024 |
Postes actifs de Todd Davis
| Sociétés | Poste | Début |
|---|---|---|
| LIGAND PHARMACEUTICALS INCORPORATED | Chief Executive Officer | 05/12/2022 |
| CHROMOCELL THERAPEUTICS CORPORATION | Chairman | 01/01/2023 |
Helomics Corp.
 Helomics Corp. Medical/Nursing ServicesHealth Services Helomics Corp. provides cancer care development and treatment consulting services. Its products include chemoFx, biospeciFx, geneFx colon and geneFx lung. It also offers research and development services. The company was founded in 1995 and is headquartered in Pittsburgh, PA. | Chairman | - |
Virocell Biologics Ltd.
 Virocell Biologics Ltd. BiotechnologyHealth Technology Virocell Biologics Ltd. is an innovation-driven Contract Development and Manufacturing Organization (CDMO) that manufactures viral vectors and gene-modified cells to enable novel cell and gene therapies to enter clinical trials. The company is based in London, UK. The British company leverages its expertise in vector manufacture directly into the production of gene-modified cells, both adherent cells such as Mesenchymal Stromal/Stem cells and suspension cultures such as CAR T-cells. Virocell Biologics is committed to leveraging its deep experience to rapidly design and select a manufacturing strategy best suited to the client's objectives. The company was founded by Farzin Farzaneh, John W. Hadden. John W. Hadden has been the CEO since incorporation. | Director/Board Member | - |
Benuvia Therapeutics, Inc.
 Benuvia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Benuvia Therapeutics, Inc. engages in pharmaceutical and therapeutic drug development services. The company is headquartered in Chandler, AZ. | Chief Executive Officer | - |
Palvella Therapeutics, Inc.
 Palvella Therapeutics, Inc. BiotechnologyHealth Technology Palvella Therapeutics, Inc. operates as a rare disease biopharmaceutical company. It develops and commercializes pathogenetically targeted therapies for rare genodermatoses with no approved treatments. Its products include QTORIN, PTX-022, PTX-367, and PTX-014. The company was founded by Wesley H. Kaupinen in 2015 and is headquartered in Wayne, PA. | Director/Board Member | 01/11/2017 |
Royaltyrx Capital LLC
 Royaltyrx Capital LLC Financial ConglomeratesFinance Royaltyrx Capital LLC provides investment services in the pharmaceutical industry. The American company was founded by Todd C. Davis. | Founder | 01/09/2018 |
| Harvard Business School Health Industry Alumni Association | Director/Board Member | - |
Healthcare Royalty Management LLC
 Healthcare Royalty Management LLC Investment ManagersFinance Healthcare Royalty Management LLC (Healthcare Royalty) is a private equity subsidiary of Cowen, Inc. founded in 2007 by Gregory Brown. The firm is headquartered in Stamford, Connecticut. | Founder | 10/06/2010 |
Anciens postes connus de Todd Davis
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░ ░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░ ░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░ ░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░░░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Todd Davis
| United States Naval Academy | Undergraduate Degree |
| Harvard Business School | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| ABBOTT LABORATORIES | Health Technology |
| LIGAND PHARMACEUTICALS INCORPORATED | Health Technology |
| VAXART, INC. | Health Technology |
| CHROMOCELL THERAPEUTICS CORPORATION | Health Technology |
| Entreprise privées | 17 |
|---|---|
Apax Partners, Inc.
 Apax Partners, Inc. Investment ManagersFinance Founded in 1976, Apax Partners, Inc. is a venture capital/private equity firm located in New York City. The firm is a subsidiary of London-based Apax Partners LLP | Finance |
BioDelivery Sciences International, Inc.
 BioDelivery Sciences International, Inc. Pharmaceuticals: MajorHealth Technology BioDelivery Sciences International, Inc. operates as a pharmaceutical company engaged in the development and commercialization of new applications of approved therapeutics to address important unmet medical needs. Its products include Symproic and Belbuca. The company was founded on January 6, 1997 and is headquartered in Raleigh, NC. | Health Technology |
AcuFocus, Inc.
 AcuFocus, Inc. Medical SpecialtiesHealth Technology AcuFocus, Inc. develops KAMRA inlay for the treatment of presbyopia. Its KAMRA inlay is an intra-corneal inlay designed to create a small aperture effect, allowing the eye to see near and intermediate objects more clearly. The company was founded in 2001 and is headquartered in Irvine, CA. | Health Technology |
Verus Pharmaceuticals, Inc.
 Verus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Verus Pharmaceuticals, Inc. was provided pediatric-oriented pharmaceutical products. The company was founded by David A. Socks, James Carroll Blair, Robert W. Keith, Cam L. Garner and David F. Hale in 2002 and was headquartered in San Diego, CA. | Health Technology |
Elan Pharmaceuticals, LLC
 Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Health Technology |
Cowen Group, Inc. /Old/
 Cowen Group, Inc. /Old/ Investment Banks/BrokersFinance Cowen Group, Inc. provides investment banking for small to midsized companies in the alternative energy, consumer health care, media, technology, and telecommunications industries. It offers mergers and acquisitions advice, securities underwriting, equity offerings, private equity placements, and market-making. The company was founded in 1918 and is headquartered in New York, NY. | Finance |
Paul Capital Partners LP
 Paul Capital Partners LP Investment ManagersFinance Founded in 1991 by Philip Paul, Paul Capital Partners LP is a private equity firm located in San Francisco with additional offices in New York City, Hong Kong, London, Paris and São Paulo. | Finance |
Artes Medical, Inc.
 Artes Medical, Inc. Financial ConglomeratesFinance Artes Medical, Inc. is a medical technology company. It is focused on developing, manufacturing and commercializing a new category of injectable aesthetic products for the dermatology and plastic surgery markets. Its products include ArteFill which is a non-resorbable aesthetic injectable implant for the correction of facial wrinkles known as smile lines, or nasolabial folds, for commercial sale in the U.S. The company was founded on August 24, 1999 and is headquartered in San Diego, CA. | Finance |
Helomics Corp.
Helomics Corp. Medical/Nursing ServicesHealth Services Helomics Corp. provides cancer care development and treatment consulting services. Its products include chemoFx, biospeciFx, geneFx colon and geneFx lung. It also offers research and development services. The company was founded in 1995 and is headquartered in Pittsburgh, PA. | Health Services |
Healthcare Royalty Management LLC
Healthcare Royalty Management LLC Investment ManagersFinance Healthcare Royalty Management LLC (Healthcare Royalty) is a private equity subsidiary of Cowen, Inc. founded in 2007 by Gregory Brown. The firm is headquartered in Stamford, Connecticut. | Finance |
Suneva Medical, Inc.
 Suneva Medical, Inc. Electronic Equipment/InstrumentsElectronic Technology Suneva Medical, Inc. develops, manufactures and commercializes novel, differentiated aesthetic products for the dermatology, plastic, and cosmetic surgery markets. It offers ArteFill, ReFissa, Bellafill, and ReGenica Skincare products. The company is headquartered in San Diego, CA. | Electronic Technology |
| Harvard Business School Health Industry Alumni Association | |
Nuron Biotech, Inc.
 Nuron Biotech, Inc. BiotechnologyHealth Technology Nuron Biotech, Inc. markets and develops vaccines for the prevention and treatment of infectious diseases. It develops novel biologics and vaccines for the prevention and treatment of neurodegenerative and infectious diseases. The firm is advancing products to meet unmet medical needs in the areas of multiple sclerosis, alzheimer's, hepatitis b and hepatitis c for patients across the globe. The company was founded by Vithalbhai Dhaduk, Shankar Musunuri and David Zeng in 2009 and is headquartered in Exton, PA. | Health Technology |
Palvella Therapeutics, Inc.
Palvella Therapeutics, Inc. BiotechnologyHealth Technology Palvella Therapeutics, Inc. operates as a rare disease biopharmaceutical company. It develops and commercializes pathogenetically targeted therapies for rare genodermatoses with no approved treatments. Its products include QTORIN, PTX-022, PTX-367, and PTX-014. The company was founded by Wesley H. Kaupinen in 2015 and is headquartered in Wayne, PA. | Health Technology |
Royaltyrx Capital LLC
Royaltyrx Capital LLC Financial ConglomeratesFinance Royaltyrx Capital LLC provides investment services in the pharmaceutical industry. The American company was founded by Todd C. Davis. | Finance |
Benuvia Therapeutics, Inc.
Benuvia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Benuvia Therapeutics, Inc. engages in pharmaceutical and therapeutic drug development services. The company is headquartered in Chandler, AZ. | Health Technology |
Virocell Biologics Ltd.
Virocell Biologics Ltd. BiotechnologyHealth Technology Virocell Biologics Ltd. is an innovation-driven Contract Development and Manufacturing Organization (CDMO) that manufactures viral vectors and gene-modified cells to enable novel cell and gene therapies to enter clinical trials. The company is based in London, UK. The British company leverages its expertise in vector manufacture directly into the production of gene-modified cells, both adherent cells such as Mesenchymal Stromal/Stem cells and suspension cultures such as CAR T-cells. Virocell Biologics is committed to leveraging its deep experience to rapidly design and select a manufacturing strategy best suited to the client's objectives. The company was founded by Farzin Farzaneh, John W. Hadden. John W. Hadden has been the CEO since incorporation. | Health Technology |
